FDA Approved: VOTRIENT — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved VOTRIENT (pazopanib hydrochloride) under an Original Application for cancer indications, marking pazopanib’s initial approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Votrient (Pazopanib)

Snippet

ORIG AP for VOTRIENT (PAZOPANIB HYDROCHLORIDE)